Disruptive Innovations – Boston

 

 

Last week, Dr. Jules T. Mitchel (standing) updated the participants at the meeting on Disruptive Innovations in Boston. The presentation was an update of Target Health’s progress on its approaches to eSource and risk-based monitoring in an ongoing Phase 3 program. After the presentation, a detailed interview occurred with Craig Lipset (seated left), Head of Clinical Innovation, Development Operations within Worldwide Research & Development at Pfizer and Dr. John Orloff (seated right), Chief Medical Officer and Senior Vice President, Global Development at Novartis. Craig and John were chairpersons of the conference together with Dr. Andreas Koester, Head, Clinical Trial Innovation / External Alliances, at Janssen.

 

 

For more information about Target Health contact Warren Pearlson (212-681-2100 ext. 104). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel or Ms. Joyce Hays. The Target Health software tools are designed to partner with both CROs and Sponsors. Please visit the Target Health Website, and if you like the weekly newsletter, ON TARGET, you’ll love the Blog.

Comments

Leave a Reply

You must be logged in to post a comment.